#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebral amyloid angiopathy Cryoglobulinaemia Frostbite Erdheim-Chester disease Osteogenesis imperfecta Aicardi-Goutieres syndrome Ductal adenocarcinoma of pancreas Gaucher's disease type III Fms-like tyrosine kinase 3 positive CDKL5 deficiency disorder Bronchopulmonary aspergillosis Neutropenia Neurodermatitis B-cell lymphoma recurrent Acute myeloid leukaemia More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Diagnostics Rhabdomyosarcoma recurrent – Treatment Advanced systemic mastocytosis Netherton’s syndrome – Basic Information Rosai-Dorfman syndrome Chondrosarcoma – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Behcet’s syndrome – Trials in Disease Myelodysplastic syndrome with excess blasts – Diagnostics Ehlers-Danlos syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dabigatran Etexilate Inavolisib Imiglucerase Ruxolitinib Atl001 D,L-Lysine Acetylsalicylate Diphenhydramine Hydrochloride Atenolol Elacestrant Dihydrochloride Hct116-A Onfekafusp Alfa Apadamtase Alfa Exl01 Sodium Gluconate E2814 Rtp-026 Sodium Betula Alba Pollen Extract Agomelatine Tazobactam Sodium Masupirdine More therapies…

    Learn about Your Condition

    Chondropathy Gender dysphoria Labour pain Haematological malignancy Gastric cancer recurrent Ovarian cancer stage IV Pancreatitis chronic Cholangiosarcoma Squamous cell carcinoma Hairy cell leukaemia recurrent Diabetic gastroparesis Encephalitis Japanese B Hypotension Malignant melanoma stage III Oral lichen planus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Durvalumab and Bevacizumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Dextrose Bp
    • Bevacizumab
    • Infliximab
    Austria France Germany Italy Poland

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Opevesostat Tosilate
    • Prednisone Acetate
    Czechia Estonia France Germany Greece Hungary +9

  • Study on the Effects of Prasinezumab in Patients with Early Parkinson’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Prasinezumab
    Austria France Germany Spain

  • Study on the Effectiveness of Isoflurane, Propofol, and Midazolam for Sedation in Patients with Severe Brain Injuries

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Propofol
    Spain

  • Study on Olaparib and Durvalumab for Patients with Advanced Ovarian Cancer Undergoing Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    • Olaparib
    Germany

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Azithromycin
    • Clarithromycin
    • Erythromycin
    Belgium Croatia Czechia Estonia France Germany +7
Previous Page
1 … 451 452 453 454 455 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!